Literature DB >> 1086604

Histopathology and ultrastructure of busulfan-induced cataract.

N A Hamming, D J Apple, M F Goldberg.   

Abstract

A 49-year-old man with chronic myelogenous leukemia developed dense posterior subcapsular cataracts and punctate cortical opacities after five years of busulfan (Myleran) therapy. We found that the histopathologic appearance of busulfan-induced cataracts is similar to other forms of human and experimental cataracts, regardless of cause. Ultrastructural examination revealed cortical liquefaction with formation of Morgagnian droplets, involving primarily the region from the equator to the posterior subcapsular space. In contrast to previous findings in rats, we observed posterior migration of equatorial nuclei and bladder cell formation. Also present were socalled crystalloid rays and abundant degenerate lens fiber membranes manifested as mutli-layered, irregularly folded configurations resembling myelin figures.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086604     DOI: 10.1007/bf00414363

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  12 in total

1.  INFLUENCE OF MYLERAN ON CELL PROLIFERATION IN THE LENS EPITHELIUM.

Authors:  P GRIMES; L VONSALLMANN; A FRICHETTE
Journal:  Invest Ophthalmol       Date:  1964-12

2.  An experimental study on the chronic toxicity of myleran and its influence upon the lens, endocrine glands and internal organs of rats.

Authors:  F KANDORI; S KURIMOTO
Journal:  Acta Pathol Jpn       Date:  1960-01

3.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

4.  Cataracts induced by the polypeptide antibiotic polymyxin B sulfate.

Authors:  E Cotlier; D Apple
Journal:  Exp Eye Res       Date:  1973-06       Impact factor: 3.467

5.  Cataract after busulphan treatment.

Authors:  M P Ravindranathan; V J Paul; E T Kuriakose
Journal:  Br Med J       Date:  1972-01-22

6.  Intraocular injection of gentamicin. Toxic effects of clearance.

Authors:  G A Peyman; D R May; E S Ericson; D Apple
Journal:  Arch Ophthalmol       Date:  1974-07

7.  Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy.

Authors:  S M Podos; G P Canellos
Journal:  Am J Ophthalmol       Date:  1969-09       Impact factor: 5.258

8.  Interference with cell proliferation and induction of polyploidy in rat lens epithelium during prolonged myleran treatment.

Authors:  P Grimes; L Von Sallmann
Journal:  Exp Cell Res       Date:  1966-05       Impact factor: 3.905

9.  Clinical and morphological side-effects of busulfan (Myleran) treatment.

Authors:  S Dahlgren; G Holm; N Svanborg; R Watz
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

10.  Cataracts produced in rats by 1, 4-dimethanesulfonoxybutane (myleran).

Authors:  C SOLOMON; A E LIGHT; E J DE BEER
Journal:  AMA Arch Ophthalmol       Date:  1955-12
View more
  1 in total

Review 1.  Ocular toxicity of systemic anticancer chemotherapy.

Authors:  Afekhide Ernest Omoti; Caroline Edijana Omoti
Journal:  Pharm Pract (Granada)       Date:  2006-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.